NIH Director Ignores Proposed Funding Based On HHS Goals In Budget Request
This article was originally published in The Tan Sheet
Francis Collins tells a House Appropriations subcommittee that a proposed decrease in NIH funding going toward “advancing scientific knowledge and innovation” will not affect how grants and research dollars are allocated.
You may also be interested in...
FDA Gets $91 Million Boost, Sequestered User Fees In 2014 Appropriation
A 2014 omnibus appropriations bill agreed to by Senate and House appropriators would give FDA $2.55 billion in discretionary funding, a $91 million increase. In news applauded by the device industry, the bill would also make available $85 million in previously sequestered FDA user fees.
US FDA Formalizes ‘One-Trial’ Approach For Oncology Accelerated Approval
Draft guidance gives recommendations for conducting one randomized controlled trial to generate the evidence for accelerated approval and confirm clinical benefit.
US FDA Program Streamlining COVID-19 Treatment Development Still Working As Emergency Ends
Any program changes would not occur until after a thorough assessment, the agency said.